Richard Christopher Lexaria Bioscience Corp. (LEXX) insider trading activity

Richard Christopher is Chief Executive Officer of Lexaria Bioscience Corp.. Currently has a direct ownership of 65,000 shares of LEXX, which is worth approximately $53,950. The most recent transaction as insider was on Jul 29, 2025, when has been sold 15,000 shares (Common Shares) at a price of $0.91 per share, resulting in proceeds of $13,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65K

30.0% 3M change

n/a 12M change

Total Value Held $53,950

RICHARD CHRISTOPHER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 29 2025	BUY Open market or private purchase	$13,650 $0.91 p/Share	15,000 Added 18.75%	65,000 Common Shares
Dec 03 2024	BUY Open market or private purchase	$67,114 $2.47 p/Share	27,172 Added 35.21%	50,000 Common Shares
Dec 02 2024	BUY Open market or private purchase	$51,134 $2.24 p/Share	22,828 Added 50.0%	22,828 Common Shares

Also insider at

NVIV

INVIVO THERAPEUTICS HOLDINGS CORP. Healthcare

Chief Financial Officer